4.5 Article

International differences in drug prices

期刊

ANNUAL REVIEW OF PUBLIC HEALTH
卷 25, 期 -, 页码 475-495

出版社

ANNUAL REVIEWS
DOI: 10.1146/annurev.publhealth.25.101802.123042

关键词

prescription drugs; price discrimination; pharmaceutical research and development; drug price regulation

向作者/读者索取更多资源

This paper addresses how and why drug prices differ across countries. Studies of international variation in drug prices reach varied conclusions owing to methodological and data disparities. Price differences do exist across countries, with the United States footing the highest bill, but the differences are not nearly as large as they appear at first glance. The higher prices in the United States are concentrated among a subset of brandname drugs and among those without insurance covering drugs. Some U.S. health plans obtain price concessions from manufacturers similar to those obtained by national governments. Price concessions occur whenever purchasers are willing to let price be a consideration in decisions about access and utilization. In low-income countries the vast majority are unwilling to pay for effective drugs simply because they are unable to pay. Low-income nations need more price discrimination-and vastly lower prices-if they are ever to afford the world's most effective medicines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据